However, in patients in whom this gene is not altered, it is recommended to exclude mutations in ACVLR1, ENG, MADH4, and GDF2, the first three of which are also related to HHT. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.